CAMEO+ eventCORPORATE2026-04-17馃嚭馃嚫
Orthogon Therapeutics raises additional $11M for BK virus antiviral program
source: Orthogon Therapeutics
On 2026-04-17, Orthogon Therapeutics announced the closing of a follow-on $11 million financing for its BK virus antiviral drug program. The company said the round brings its total capital raised to $36 million and will support continued development of its first-in-class antiviral candidate.
0.14Significance2.0Magnitude0.1Systemic0.2Market1Articles
Location
North AmericaUnited StatesNorth America39.828, -98.579
Story Links